There have been two very important influences on the management of COPD in primary care in the UK in the last few years. The first of these was the negotiation of a new contract for GPs in 2003 (the GMS contract) and the second was the publication in 2004 of the first national guidelines for the management of COPD produced by NICE. So what exactly has the impact of these developments been on COPD management in the UK?
This title provides a commentary on the impact of QOF and NICE guidelines on COPD care. It provides a summary of the NICE guidelines and asks what do the NICE guidelines add? In addition to providing guideline recommendations, it also looks at the following key areas of pharmacotherapy:
- Inhaled bronchodilators - Theophylline - Corticosteroids - Mucolytics - Antidepressants for comorbid depression - Palliative pharmacotherapy - Pulmonary rehabilitation - Oxygen therapy and respiratory failure - Surgery - Managing exacerbations - Non-invasive ventilation - Implementation in practice - COPD requires multidisciplinary management - Audit criteria
Product samples
A sample for this product is available. Please Login/Register to download this sample.
